Lipoic Acid‐Intervened Decellularized Stem Cell Spheroid‐Based Injectable Granular Gel for Diabetic Tissue Regeneration
Advanced Science · 2026-06 · 13 (36)
DOI: 10.1002/advs.202521924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 07.04.2026. Verfasst von Tao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Cosmetic Surgery, Tongji Hospital, School of Medicine Tongji University, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Thioctic Acid, Stem Cells, Tissue Engineering, Spheroids, Cellular. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Advancements in tissue engineering have revolutionized therapeutic paradigms for diabetic tissue defects; however, the lack of applicable scaffold containing various bioactive substance aggregates remained a critical bottleneck hindering satisfactory repair effect. In this study, adipose‐derived stem cells (ADSCs) were functionally re‐engineered using lipoic acid (LA) to fabricate a novel LA‐intervened stem cell spheroid (LA‐SCS) with enhanced paracrine activity and extracellular matrix (ECM) biosynthetic capacity. Subsequent decellularization mitigated immunogenicity, yielding LA‐intervened decellularized stem cell spheroid (LA‐dSCS). In vitro assays confirmed its immunomodulatory potency, as evidenced by the activation of signaling cascades associated with macrophage reprogramming, homeostasis, and autophagy. Furthermore, leveraging the intrinsic viscoelastic properties of the LA‐dSCS, a convenient preparation method for preparing LA‐dSCS derived injectable material was established, wherein LA‐dSCS micro‐particles assemble into LA‐dSCS granular gel. In vivo studies using diabetic rat models demonstrated closure of both wound and cranial defects. Collectively, this study established a biomimetic engineering strategy that integrates cell‐free bioactive aggregates with injectable granular gels, offering a novel proof‑of‑concept strategy for the regeneration of complex diabetic tissue defects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic and Cosmetic Surgery, Tongji Hospital, School of Medicine Tongji University, Shanghai, P. R. China.
- Institute of Aesthetic Plastic Surgery and Medicine, School of Medicine, Tongji University, Shanghai, P. R. China.
- Department of Polymer Materials, School of Materials Science and Engineering, Shanghai University, Shanghai, P. R China.
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Key Laboratory of Tissue Engineering, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
ORCID-Profile: Tao Wang, Kunxi Zhang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Wang, T., Fang, H., Qi, L., Myoungseop, S., Khan, A., Gong, L., Zhou, G., Zhang, K., & Cui, H. (2026). Lipoic Acid‐Intervened Decellularized Stem Cell Spheroid‐Based Injectable Granular Gel for Diabetic Tissue Regeneration. Advanced Science, 13(36). https://doi.org/10.1002/advs.202521924
Vancouver
Wang T, Fang H, Qi L, Myoungseop S, Khan A, Gong L, et al. Lipoic Acid‐Intervened Decellularized Stem Cell Spheroid‐Based Injectable Granular Gel for Diabetic Tissue Regeneration. Advanced Science. 2026;13(36). doi:10.1002/advs.202521924
BibTeX
@article{Wang2026,
author = {Wang, Tao and Fang, Haowei and Qi, Lili and Myoungseop, Song and Khan, Aawrish and Gong, Lunli and Zhou, Guangdong and Zhang, Kunxi and Cui, Haiyan},
title = {Lipoic Acid‐Intervened Decellularized Stem Cell Spheroid‐Based Injectable Granular Gel for Diabetic Tissue Regeneration},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {36},
doi = {10.1002/advs.202521924}
}
EUVIMED